Furthermore, among the 60 lung cancer patients, the average concentration of IL10 was obviously higher in stages III & IV than in stages I & II (Supplementary Table S1), implying an involvement of IL10 in tumor progression. This evidence concerns the gene IL10 and lung carcinoma.